IV 
115TH CONGRESS 
2D SESSION 
H. RES. 1135 
Raising awareness of the lifesaving role of three-dimensional (3D) digital 
breast tomosynthesis screening in detection and treatment of breast cancer. 
IN THE HOUSE OF REPRESENTATIVES 
OCTOBER 26, 2018 
Mr. PAULSEN submitted the following resolution; which was referred to the 
Committee on Energy and Commerce 
RESOLUTION 
Raising awareness of the lifesaving role of three-dimensional 
(3D) digital breast tomosynthesis screening in detection 
and treatment of breast cancer. 
Whereas, in 2012, the Food and Drug Administration ap-
proved three-dimensional (3D) digital tomosynthesis, a 
modification of digital mammography that uses a moving 
x-ray source and a digital detector that allows for the re-
construction of a three-dimensional dataset; 
Whereas 3D digital tomosynthesis dramatically improves the 
imaging of breast lesions and breast cancer by elimi-
nating overlap from surrounding tissues and structures; 
Whereas peer-reviewed research published in the Journal of 
the American Medical Association in 2014 has docu-
mented that tomosynthesis used with digital mammog-
raphy is associated with up to a 41-percent increase in 
VerDate Sep 11 2014 
20:52 Oct 26, 2018
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR1135.IH
HR1135
pamtmann on DSKBFK8HB2PROD with BILLS
•HRES 1135 IH 
the detection of invasive cancers and up to a 37-percent 
drop in patient recalls to have additional breast imaging 
workup, such as a diagnostic mammogram or a breast 
ultrasound, due to ambiguous results; 
Whereas earlier detection of breast cancers is positively cor-
related to improved patient survival and outcomes and re-
duced cost of treatment; 
Whereas peer-reviewed research has concluded that broader 
adoption of this technology presents an opportunity to 
deliver value-based care to the Medicaid population and 
to address disparities and barriers to access to preventive 
care for some of the Nation’s most vulnerable citizens; 
Whereas while the adoption of 3D tomosynthesis has been 
growing, 52 percent of United States mammography fa-
cilities are still without this lifesaving technology; 
Whereas Medicare covers 3D tomosynthesis and it is esti-
mated that at least 86 percent of covered lives in the pri-
vate insurance market are covered for this technology; 
and 
Whereas the utilization and coverage of 3D tomosynthesis 
can save lives, improve treatment regimens, and reduce 
health care costs: Now, therefore, be it 
Resolved, That the House of Representatives— 
(1) acknowledges the immense value of three-di-
mensional (3D) digital breast tomosynthesis; 
(2) encourages all Federal health care programs 
to promote access and coverage of this lifesaving 
technology; 
VerDate Sep 11 2014 
20:52 Oct 26, 2018
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\HR1135.IH
HR1135
pamtmann on DSKBFK8HB2PROD with BILLS
•HRES 1135 IH 
(3) calls upon all private sector insurers to 
cover and fairly reimburse for this technology; and 
(4) supports efforts by the public health com-
munity to publicize the merits and availability of 3D 
digital breast tomosynthesis. 
Æ 
VerDate Sep 11 2014 
20:52 Oct 26, 2018
Jkt 089200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\HR1135.IH
HR1135
pamtmann on DSKBFK8HB2PROD with BILLS